IPP Bureau
Lonza extends collaboration with Biopharma company
By IPP Bureau - July 19, 2021
As per the agreement, Lonza will provide commercial-scale manufacture of monoclonal antibodies
Veeda Clinical Research acquires majority stake in Bioneeds
By IPP Bureau - July 18, 2021
Growing R&D budgets of global pharmaceutical companies is the opportunity that Veeda and Bioneeds expect to capitalise on.
Cadila Healthcare completes sale of animal healthcare business
By IPP Bureau - July 16, 2021
The company had announced the expected date of completion of sale and disposal of the said undertaking is 90 days from the date of signing the Definitive Agreements.
Jubilant Pharmova’s Roorkee facility placed under import alert
By IPP Bureau - July 16, 2021
The company will engage with the agency to resolve the import alert at the earliest and ensure cGMP compliance.
Caplin gets USFDA approval for Sumatriptan
By IPP Bureau - July 15, 2021
Sumatriptan Injection USP is indicated in adults for acute treatment of migraine with or without aura, and acute treatment of cluster headache
Brooks announces new investments to build an integrated carbapenem business
By IPP Bureau - July 15, 2021
SteriScience will infuse an additional amount of Rs. 74.5 crore, making a total investment commitment of Rs. 114.5 crore in BSL
Vikas Lifecare acquires 22.04% stake in Advik Laboratories
By IPP Bureau - July 15, 2021
Vikas Lifecare has already paid Rs. 25 million to the Advik bankers till date and the remaining amount shall also be paid within July 2021, making Advik a debt free company
Sequent Scientific announces EUGMP approval for tablets
By IPP Bureau - July 15, 2021
The company has already embarked upon significant expansion in Turkey
Borealis appoints IMCD as healthcare portfolio distributor
By IPP Bureau - July 13, 2021
The distribution agreement is effective from 1 October 2021 and applies to Bormed products used in pharmaceutical packaging, medical and diagnostic devices
Unichem receives tentative approval for ANDA of Sitagliptin tablets
By IPP Bureau - July 11, 2021
Sitagliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
Metropolis Healthcare gets approval for acquisition of Dr. Ganesan's Hitech Diagnostic Centre
By IPP Bureau - July 11, 2021
In the interim, the statutory approvals obtained by the company under SEBI ICDR have lapsed in accordance with applicable law and are required to be re-obtained
Marksans Pharma shareholders vote for warrants worth Rs. 365 Cr
By IPP Bureau - July 11, 2021
The shareholders have also ratified the Board’s approval to allot 10 lakhs warrants to the Promoter, Managing Director and CEO, Mark Saldanha at the said price of Rs. 74 per warrant
Alembic announces USFDA approval for Desipramine Hydrochloride Tablets
By IPP Bureau - July 09, 2021
The company has a cumulative total of 147 ANDA approvals (129 final approvals and 18 tentative approvals) from USFDA
Pfizer and BioNTech expects third dose clinical studies of COVID-19 vaccine in August
By IPP Bureau - July 09, 2021
The companies anticipate clinical studies to begin in August, subject to regulatory approvals
RDIF and Morepen announce production of test batch of Sputnik V
By IPP Bureau - July 08, 2021
The first batch will be shipped to the Gamaleya Center for the quality control
